Back to results
US 2022/0090133 A1Published application
Use of oncolytic viruses for the treatment of cancer
AssigneeAmgen Inc.
InventorsJason James DEVOSS, Walter Hans MEISEN, Christine Elaine TINBERG, Keegan COOKE, Achim Klaus MOESTA
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of oncolytic viruses (e.g., modified HSV-1 viruses) for the treatment of various types of cancer. In addition, the present invention relates to compositions and kits relating to such uses of oncolytic viruses.
Claims34
An oncolytic virus comprising:
- a nucleic acid sequence encoding a heterologous dendritic cell growth factor;
- and
- a nucleic acid sequence encoding a first heterologous cytokine.
Dependencies are inferred from the claim text.